06-1 - Lori J Wirth - Nasopharyngeal carcinoma (Part 1)
1 Nasopharyngeal Carcinoma: Site specific approaches
2 Epidemiologic features
3 Anatomic features of NPC
4 Sensitivity to chemotherapy and radiotherapy
5 Up-front NPC treatment
6 Up-front NPC treatment: data basis
7 Intergroup 0099 Ph III: RT vs RCT
8 Intergroup 0099: results
9 Intergroup 0099: issues
10 What's wrong with adjuvant PF?
11 Subsequent Asian trials contradictory
12 Meta-analysis: MAC-NPC Collaborative Group
13 Shift from adjuvant to induction CT
14 NPC trials currently underway
15 Targets for targeted therapy in NPC
16 EBV as a therapeutic target in NPC
17 Proof of principle EBV-specific immunotherapy
18 EBV-specific immunotherapy: pilot Phase I
19 EBV-specific immunotherapy: challenges
20 Summary statements on NPC
-
Category
No comments found